1.Clinical Significance of Hepatitis Virus Antigens and Antibodies.
Journal of the Korean Pediatric Society 1983;26(5):407-411
No abstract available.
Antibodies*
;
Hepatitis Viruses*
;
Hepatitis*
2.A Clinical Study of Type A Hepatitis Confirmed by IgM Anti-HAV.
Oh Kyung LEE ; Sung Seek LEE ; Keun Chul CHOI ; Myung Ho LEE ; Sook Ja PARK
Journal of the Korean Pediatric Society 1984;27(8):778-785
No abstract available.
Hepatitis A Antibodies*
;
Hepatitis*
;
Immunoglobulin M*
3.Hepatitis C virus antibodies among liver diseases.
Sook Ja PARK ; Jin Sook LEE ; Hyung KIM ; Joon Hyun PARK
Korean Journal of Clinical Pathology 1991;11(2):485-491
No abstract available.
Hepacivirus*
;
Hepatitis C Antibodies*
;
Hepatitis C*
;
Hepatitis*
4.Prevalence of antibodies against hepatitis viruses(HAV, HBV and HCV) and seroconversions of HBsAb and HBsAg in vaccinees.
Soo Kwang LEE ; Chul Soon CHOI ; Sang In CHUNG ; Yong Tae YANG
Journal of the Korean Society of Virology 1991;21(2):151-161
No abstract available.
Antibodies*
;
Hepatitis B Surface Antigens*
;
Hepatitis*
;
Prevalence*
5.Prevalence of hepatitis C virus antibodies in various liver diseases and posttransfusion hepatitis.
Sung Min PARK ; Kee Joong JU ; Chang Hwan LEE ; Young Woong SHIM ; Kap Young SONG
Korean Journal of Medicine 1993;45(2):154-160
No abstract available.
Hepacivirus*
;
Hepatitis C Antibodies*
;
Hepatitis C*
;
Hepatitis*
;
Prevalence*
6.Status of Serum Hepatitis C Virus Antibodies in Hansen's Disease.
Jong Pill KIM ; Yun Sil KIM ; Tea Byoung PARK ; Young Hoon KO
Korean Leprosy Bulletin 2001;34(2):81-89
According to the reports, the prevalence of anti-HCV is about 1%. In past, the results of the prevalence of HBs Ag & HBs Ab in the patients of Hansen's disease were reported. But we don't know about that of anti-HCV. So we study about the prevalence of serum anti-HCV of 60 patients & PALS of Hansen's disease. And we test about Alk. Phosp., ALT, AST, Gtlc HBs Ag & HBs Ab. 1. The prevalence of anti-HCV is 8.33%. It is higher than past reports(about 1-2%). 2. The prevalence of HBs Ag is 3.4% & that of HBs Ab is 36.3%. 3. Because of the high prevalence of anti-HCV in the patients of Hansen's disease & PALS, we think that more studies are need about it.
Hepacivirus*
;
Hepatitis C Antibodies*
;
Hepatitis C*
;
Hepatitis*
;
Humans
;
Leprosy
;
Prevalence
7.The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in Korea.
Hyun Chin CHO ; Yu Jin KIM ; Moon Seok CHOI ; Joon Hyeok LEE ; Kwang Cheol KOH ; Byung Chul YOO ; Seung Woon PAIK
Gut and Liver 2011;5(2):217-220
BACKGROUND/AIMS: The aim of this study was to evaluate the seroconversion rate of a hepatitis A virus (HAV) vaccination in patients with hepatitis B virus (HBV)-related chronic liver disease (CLD). METHODS: Analyses were conducted using clinical records from 94 patients with chronic HBV infection who were seronegative for IgG anti-HAV antibodies between September 2008 and June 2009. Two doses of an HAV vaccine were administered 24 weeks apart. A third vaccine dose was administered only for patients seronegative for anti-HAV antibodies at week 48. RESULTS: The seroconversion rate of anti-HAV following the two-dose vaccination was 86.17%. The seroconversion rate of anti-HAV was not significantly different according to age or status of liver disease. The rate was higher in female than in male patients. A third HAV vaccine dose was administered to 13 patients seronegative for anti-HAV after the two-dose regimen, and 84.62% of these patients showed seroconversion at week 72. CONCLUSIONS: HAV vaccination is effective in most Korean patients with HBV-related CLD, and it might be necessary to evaluate three-dose vaccination approach for non-responders to the conventional regimen to maximize the success of an HAV vaccination program.
Antibodies
;
Female
;
Hepatitis
;
Hepatitis A
;
Hepatitis A Antibodies
;
Hepatitis A virus
;
Hepatitis B
;
Hepatitis B virus
;
Hepatitis B, Chronic
;
Humans
;
Immunoglobulin G
;
Korea
;
Liver
;
Liver Diseases
;
Male
;
Vaccination
8.Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
Jun SUK ; Il JOO ; Gye Cheol KWON
Korean Journal of Nephrology 1992;11(4):437-440
No abstract available.
Antibodies*
;
Hepacivirus*
;
Hepatitis C*
;
Hepatitis*
;
Humans
;
Prevalence*
;
Renal Dialysis*
9.Study on the vertical transmission of antigens and antibodies of viral hepatitis B in Korean pregnant women.
Byung Hee SUH ; Jin Ki HONG ; Ho Jun JANG ; Ju Yup HUH ; Jae Hyun LEE ; Kyng Ho KIM
Korean Journal of Obstetrics and Gynecology 1992;35(2):195-212
No abstract available.
Antibodies*
;
Female
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Pregnant Women*
10.Rate of HBsAg and anti-HCV carriers among blood donors at Thua Thien Hue province during 5 years 1997 - 2001
Journal of Practical Medicine 2002;435(11):12-14
The rate of HBsAg carriers among blood donors at at Thua Thien Hue province during 5 years (1997 - 2001) is relative high, with 13.57% on average. At the same time, the incidence of HCV infection is lower than other areas (with mean 0.64%). The rate of HBsAg carrier is higher in rural than in Hue city (14.72% vs. 12.27%). The young adults in precincts have higher HBsAg incidence than in other groups.
Blood Donors
;
Hepatitis B Surface Antigens
;
Hepatitis C Antibodies